share_log

RBC Capital Reiterates Outperform on Moderna, Maintains $125 Price Target

Benzinga ·  Jan 12 11:28

RBC Capital analyst Luca Issi reiterates Moderna (NASDAQ:MRNA) with a Outperform and maintains $125 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment